Strategy's STRC Hits $100, Unlocking Bitcoin Buying Spree

$100. This single number just unlocked billions in potential bitcoin purchases. Strategy's (MSTR) perpetual preferred equity STRC reclaimed its $100 par value Wednesday for the first time since mid-January—and that's not just a stock recovery story. It's the green light for the world's largest corporate bitcoin holder to resume its aggressive accumulation strategy.

The $100 Gateway

Here's why this matters: STRC trading at or above par enables Strategy to conduct at-the-market (ATM) offerings for additional bitcoin acquisitions. It's a built-in mechanism that essentially puts bitcoin buying on autopilot when market conditions align.

The last time STRC hit $100 was January 16, when bitcoin hovered near $97,000. But as bitcoin crashed to $60,000 by February 5, STRC tumbled to $93, effectively shutting down Strategy's funding pipeline. Now, with bitcoin at $67,500, STRC has somehow managed to climb back to par—a signal that investors still believe in Strategy's bitcoin-heavy playbook.

The 11.25% Monthly Dividend Gambit

Sponsored

Advertise with Us

[email protected]

Sponsored

What's keeping STRC afloat? A hefty 11.25% annual dividend paid monthly. Strategy has been tweaking this rate monthly to manage volatility and incentivize trading near par—recently hiking it to the current 11.25% yield.

For income-hungry investors, it's an attractive proposition. But here's the catch: every dividend payment is cash flowing out of Strategy's treasury, cash that could otherwise buy more bitcoin. It's a delicate balancing act between attracting capital and preserving it.

The Tale of Two Stocks

While STRC celebrated its $100 comeback, Strategy's common stock (MSTR) told a different story, sliding 5% to close at $126. This divergence reveals something crucial about market psychology.

Common shareholders are essentially making a pure bitcoin bet—they feel every swing in crypto prices. STRC holders, meanwhile, are getting paid to wait, cushioned by that monthly dividend. It's the same company, but two completely different risk profiles.